Stay updated on Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    No significant changes detected in core study details, eligibility criteria, or primary outcomes; any updates appear to be minor formatting or layout adjustments that do not affect the information presented. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:24:14.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    4%
    Check dated 2025-10-06T06:38:09.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:13:35.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T20:13:58.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T17:10:46.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several key disease categories and specific terms related to diseases have been removed.
    Difference
    3%
    Check dated 2025-08-31T12:16:35.000Z thumbnail image

Stay in the know with updates to Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial page.